Picture of Coloplast A/S logo

COLO B Coloplast A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareBalancedLarge CapFalling Star

Brief: Coloplast Q3 Adjusted EBIT DKK 1.9 Bln

Aug 19 (Reuters) - Coloplast A/S COLOb.CO:

OUTLOOK FY ORGANIC GROWTH 7%

Q3 PRETAX PROFIT DKK 1,342 MILLION

Q3 EBIT MARGIN 26%

Q3 ADJUSTED EBIT DKK 1,915 MILLION

Q3 NET INCOME DKK 805 MILLION

Q3 REVENUE DKK 6,958 MILLION

Q3 EBIT DKK 1,832 MILLION

OUR Q3 PERFORMANCE WAS DRIVEN BY BROAD-BASED GROWTH ACROSS OUR CHRONIC CARE BUSINESSES, OFFSETTING CHALLENGES IN CHINA

FY 2024/25 GUIDANCE IS UNCHANGED WITH ORGANIC GROWTH OF AROUND 7% AND AN EBIT MARGIN BEFORE SPECIAL ITEMS OF 27-28%

Source text: ID:nGNE1CC9k5

Further company coverage: COLOb.CO

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Coloplast A/S

See all news